Gujarat Themis Biosyn Limited: Trading Window Closure from April 1, 2026
Gujarat Themis Biosyn Limited will close its trading window from April 1, 2026. The window will reopen 48 hours after the board meeting to approve the Q4 FY26 audited financial results.
The closure of the trading window is a standard procedure before the declaration of financial results and does not have a direct impact on the company's business operations or financial performance.
The announcement is a routine regulatory disclosure regarding the closure of the trading window and does not contain any material financial or business updates.
Gujarat Themis Biosyn Limited has announced the closure of its trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct.
The trading window will be closed effective from Wednesday, April 1, 2026. It will be reopened 48 hours after the Board of Directors declares the audited financial results for the quarter ending March 31, 2026.
The date for the Board Meeting to consider these financial results will be communicated in due course.
What to do with a filing like this
Gujarat Themis Biosyn Limited filed this with the NSE as a statutory disclosure, categorised under trading window disclosure. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gujarat Themis Biosyn Limited. Read the original for the full detail.